Kilitch Drugs (India) Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹89.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 66.51 per cent from ₹53.81 crore. This corresponds to a year-on-year *(YoY) growth of 46.33 per cent.
Operating Profit
Operating Profit stands at ₹22.14 crore, reflecting a quarter-on-quarter *(QoQ) increase of 260.00 per cent from ₹6.15 crore. This corresponds to a year-on-year *(YoY) growth of 51.64 per cent.
PBDT
PBDT stands at ₹21.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 224.50 per cent from ₹6.53 crore. This corresponds to a year-on-year *(YoY) growth of 44.15 per cent.
Profit Before Tax
Profit Before Tax stands at ₹20.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 261.54 per cent from ₹5.59 crore. This corresponds to a year-on-year *(YoY) growth of 45.92 per cent.
Net Profit
Net Profit stands at ₹14.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 245.24 per cent from ₹4.31 crore. This represents a 45.60 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Kilitch Drugs (India) Ltd Earnings
- YOY
- QOQ
Kilitch Drugs (India) Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Kilitch Drugs (India) Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Kilitch Drugs (India) Ltd Financial Reports
Kilitch Drugs (India) Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Kilitch Drugs | 2.24% | 5.78% | 34.57% | 33.51% | 92.44% | 36.80% |
| Themis Medicare | 2.52% | -0.18% | -15.15% | -4.27% | 34.04% | -14.47% |
| Bafna Pharma. | 1.99% | 8.23% | 43.05% | 104.77% | 193.10% | 166.93% |
| Shree Ganesh Rem | 0.47% | 4.23% | 12.92% | 2.88% | 46.05% | 42.08% |
| Anuh Pharma | 0.37% | -2.63% | -10.40% | 4.01% | 3.34% | -0.53% |
| Zim Laboratories | 1.71% | 4.62% | 4.32% | 25.32% | 95.09% | 99.18% |
| Amanta Healthcar | -1.07% | -3.77% | -4.22% | 7.78% | 72.86% | 45.48% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : Mukund P Mehta
E D & Wholetime Director : Bhavin M Mehta
Executive Director & MD : Mira Mehta
Independent Non Exe. Director : VASUDEV KRISHNAMURTI
Independent Non Exe. Director : Venkita Subramanian Rajan
Independent Non Exe. Director : DIPEN JAYANTILAL JAIN
Company Sec. & Compli. Officer : Pushpa Nyoupane